diprosalic lotion
organon canada inc. - betamethasone (betamethasone dipropionate); salicylic acid - lotion - 0.5mg; 20mg - betamethasone (betamethasone dipropionate) 0.5mg; salicylic acid 20mg - anti-inflammatory agents
diprolene ointment
organon canada inc. - betamethasone (betamethasone dipropionate) - ointment - 0.05% - betamethasone (betamethasone dipropionate) 0.05% - anti-inflammatory agents
diprolene cream
merck canada inc - betamethasone (betamethasone dipropionate) - cream - 0.05% - betamethasone (betamethasone dipropionate) 0.05% - anti-inflammatory agents
diprolene lotion
merck canada inc - betamethasone (betamethasone dipropionate) - lotion - 0.05% - betamethasone (betamethasone dipropionate) 0.05% - anti-inflammatory agents
lotriderm cream
organon canada inc. - betamethasone (betamethasone dipropionate); clotrimazole - cream - 0.05%; 1% - betamethasone (betamethasone dipropionate) 0.05%; clotrimazole 1% - anti-inflammatory agents
teva-topisone lotion
teva canada limited - betamethasone (betamethasone dipropionate) - lotion - 0.05% - betamethasone (betamethasone dipropionate) 0.05% - anti-inflammatory agents
teva-topisone ointment
teva canada limited - betamethasone (betamethasone dipropionate) - ointment - 0.05% - betamethasone (betamethasone dipropionate) 0.05% - anti-inflammatory agents
teva-topisone cream
teva canada limited - betamethasone (betamethasone dipropionate) - cream - 0.05% - betamethasone (betamethasone dipropionate) 0.05% - anti-inflammatory agents
ratio-topisalic lotion
teva canada limited - betamethasone (betamethasone dipropionate); salicylic acid - lotion - 0.5mg; 20mg - betamethasone (betamethasone dipropionate) 0.5mg; salicylic acid 20mg - anti-inflammatory agents
eleuphrat betamethasone 0.05% (as dipropionate) ointment tubeointment
organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: white soft paraffin; liquid paraffin - topical treatment of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lechen planus, intertrigo and psoriasis. indications as at 26 august 1992: eleuphrat is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.